Filed Under:

Glaxo To Stop Paying Doctors To Promote Drugs

Play associated audio
The head of British drug maker GlaxoSmithKline told The New York Times on Monday that the company will stop paying doctors to promote its drugs. Pharmaceutical firms commonly pay physicians to speak at medical conferences — a practice criticized as a conflict of interest.

'Not Without My Daughter' Subject Grows Up, Tells Her Own Story

"Not Without My Daughter" told the story of an American mother and daughter fleeing Iran. Now that young girl is telling her own story in her memoir, "My Name is Mahtob."

Internet Food Culture Gives Rise To New 'Eatymology'

Internet food culture has brought us new words for nearly every gastronomical condition. The author of "Eatymology," parodist Josh Friedland, discusses "brogurt" with NPR's Rachel Martin.

Proposed Climate Change Rules At Odds With U.S. Opponents

President Obama says the U.S. must lead the charge to reduce burning of fossil fuels. But American lawmakers are divided on limiting carbon emissions and opponents say they'll challenge any new rules.

Payoffs For Prediction: Could Markets Help Identify Terrorism Risk?

In a terror prediction market, people would bet real money on the likelihood of attacks. NPR's Scott Simon speaks with Stephen Carter about whether such a market could predict — and deter — attacks.

Leave a Comment

Help keep the conversation civil. Please refer to our Terms of Use and Code of Conduct before posting your comments.